echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Active Ingredient Products News > The Instruction of Tirofiban hydrochloride monohydrate

    The Instruction of Tirofiban hydrochloride monohydrate

    • Last Update: 2023-05-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Tirofiban hydrochloride monohydrate is a pharmaceutical compound that is used in the treatment of acute coronary syndrome, a group of conditions that include heart attacks and unstable angina.
    This medication works by preventing platelets from sticking together and forming clots, which can cause blockages in the coronary arteries.
    In this article, we will take a closer look at tirofiban hydrochloride monohydrate and its use in the chemical industry.


    Background


    Tirofiban hydrochloride monohydrate is a potent and selective glycoprotein IIb/IIIa inhibitor.
    It is synthesized by recombinant DNA technology using a baculovirus expression vector, and is purified by several chromatographic techniques.
    The chemical formula for tirofiban hydrochloride monohydrate is C81H115N15O18S3.
    It has a molecular weight of 1503.
    9 Da and a solubility of 2.
    7 mg/mL in water.


    Uses


    Tirofiban hydrochloride monohydrate is used in the treatment of acute coronary syndrome, a condition that can lead to heart attacks and unstable angina.
    It works by inhibiting the action of glycoprotein IIb/IIIa, a protein found on the surface of platelets.
    By inhibiting this protein, tirofiban hydrochloride monohydrate prevents platelets from sticking together and forming clots in the coronary arteries.
    This helps to improve blood flow to the heart and reduce the risk of further heart damage.


    In addition to its use in the treatment of acute coronary syndrome, tirofiban hydrochloride monohydrate has also been studied for its potential use in other medical conditions.
    These include the prevention of blood clots in patients undergoing percutaneous coronary intervention, the prevention of deep vein thrombosis and pulmonary embolism, and the reduction of thrombotic burden in patients with myocardial infarction.


    Manufacturing


    The production of tirofiban hydrochloride monohydrate involves several steps, including the cultivation of the baculovirus expression vector, the purification of the recombinant protein, and the synthesis of the hydrochloride salt.


    First, the baculovirus expression vector is cultivated in insect cells.
    This vector contains the genetic information for the production of tirofiban hydrochloride monohydrate.
    The insect cells are then harvested and the recombinant protein is extracted and purified using several chromatographic techniques.


    Next, the purified protein is subjected to a series of chemical reactions that result in the formation of tirofiban hydrochloride monohydrate.
    This involves the addition of a hydrochloride salt to the protein, which results in the formation of the final product.


    Quality Control


    The quality of tirofiban hydrochloride monohydrate is controlled by several methods, including chromatographic analysis and mass spectrometry.
    These methods are used to ensure that the final product meets the required specifications for purity, potency, and identity.


    In addition, the manufacturing process for tirofiban hydrochloride monohydrate is subject to strict regulations and guidelines.
    This ensures that the product is safe and effective for use in patients.


    Availability


    Tirofiban hydrochloride monohydrate is available in several countries under different trade names.
    In the United States, it is marketed under the trade name Aggrastat.
    In Europe, it is marketed under the trade name GiTyp



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.